The C-19 steroids 4-androstene-3,17-dione (AD), 1,4-androstadiene-3,17-dione (ADD) or 9a-hydroxy-4-androstene-3,17-dione (9OH-AD), which have been postulated as intermediates of the cholesterol catabolic pathway in Mycobacterium smegmatis, cannot be used as sole carbon and energy sources by this bacterium. Only the DkstR mutant which constitutively expresses the genes repressed by the KstR regulator can metabolize AD and ADD with severe difficulties but still cannot metabolize 9OH-AD, suggesting that these compounds are not true intermediates but side products of the cholesterol pathway. However, we have found that some M. smegmatis spontaneous mutants mapped in the PadR-like regulator (MSMEG_2868) can efficiently metabolize all C-19 steroids. We have demonstrated that the PadR mutants allow the expression of a gene cluster named C-191 (MSMEG_2851 to MSMEG_2901) encoding steroid degrading enzymes, that are not expressed under standard culture conditions. The C-191 cluster has apparently evolved independently from the upper cholesterol kstR-regulon, but both clusters converge on the lower cholesterol kstR2-regulon responsible for the metabolism of C and D steroid rings. Homologous C-191 clusters have been found only in other actinobacteria that metabolize steroids, but remarkably it is absent in Mycobacterium tuberculosis.
Introduction
Cholesterol and other steroids are abundant compounds in the environment and can be used as carbon and energy sources by different microorganisms. Apart from its environmental interest, the bacterial catabolism of steroids has attracted considerable attention because low-cost natural sterols (e.g. phytosterols) are currently biotransformed at industrial scale into valuable pharmaceutical steroids by fermentative processes (Fernandes et al., 2003; Donova and Egorova, 2012; Garc ıa et al., 2012) . This interest has strongly driven many studies of steroid catabolism in different bacteria (e.g. Mycobacterium, Rhodococcus, Gordonia and Comamonas) (Horinouchi et al., 2003; 2004; van der Geize et al., 2007; Kendall et al., 2007; Drzyzga et al., 2011; Uh ıa et al., 2012; Li et al., 2014) , but there are still genetic and biochemical questions that remain unsolved concerning this metabolism. The currently accepted cholesterol degradation route has been postulated based on biochemical and genetic studies compiled from several steroid degrading bacteria, and, as we will show in this work, this fact has caused some misinterpretations due to the convergence of different steroid catabolic pathways acting together in some microorganisms.
Many bacteria able to degrade sterols containing large aliphatic/hydrophobic side-chains, like cholesterol or phytosterols, belong to the phylum Actinobacteria. These bacteria are able to transport sterols by a specific ATPdependent transport system named Mce4 (Casali and Riley, 2007; Pandey and Sassetti, 2008; Mohn et al., 2008; Klepp et al., 2012) , being this step essential for their further mineralization. Within this phylum, one of the finest studies has been done in mycobacterial species (Andor et al., 2006; Capyk et al., 2009a,b; Garc ıa et al., 2012; Bragin et al., 2013) , because the cholesterol catabolism plays a key role in important human diseases such as tuberculosis (van der Geize et al., 2007; Pandey and Sassetti, 2008; Brzostek et al., 2009; Miner et al., 2009; Yang et al., 2009 , Hu et al., 2010 Nesbitt et al., 2010; Ouellet et al., 2011; Griffin et al., 2012; Brzezinska et al., 2013; Klink et al., 2013; Wipperman et al., 2014; VanderVen et al., 2015; Yang et al., 2015) and because most of the sterol biotransformations performed at industrial scale use environmental isolates of mycobacteria (Wei et al., 2010a; Donova and Egorova 2012; Garc ıa et al., 2012; Bhatti and Khera, 2012) . Some of these works have been conducted on Mycobacterium smegmatis mc 2 155, a non-pathogenic fast-growing mycobacterium, which has been used for years as a model system to study tuberculosis due to its close phylogenetic relationship with Mycobacterium tuberculosis (Brzostek et al., 2005; Kendall et al., 2007; Uh ıa et al., 2011; Garc ıa et al., 2012; Garc ıa-Fern andez et al., 2013; Garc ıa-Fern andez et al., 2015) .
In M. smegmatis one of the first steps in cholesterol catabolism is its transformation into cholest-4-en-3-one (cholestenone), a reaction catalysed by several 3b-hydroxysteroid dehydrogenase/isomerase activities (Uh ıa et al., 2011; Brzostek et al., 2013) . Concomitantly with the modification of steroid A-ring, at least two P450 cytochromes, named CYP125 and CYP142, initiate sterol sidechain degradation in actinobacteria (Capyk et al., 2009b; Rosłoniec et al., 2009; Ouellet et al., 2010; Garc ıa-Fern andez et al., 2013) . These CYPs perform sequential oxidations of the methyl group at C-26 to generate a carboxylic acid. This activity enables the further b-oxidation of the cholesterol side-chain that apparently finished into the central C-19 steroids, i.e. 4-androstene-3,17-dione (AD), 1,4-androstadiene-3,17-dione (ADD) or 9a-hydroxy-4-androstene-3,17-dione (9OH-AD). Thereafter, the catabolism of AD, ADD and 9OH-AD has been postulated to proceed for aerobic bacteria through a common catabolic route called 9,10-seco pathway involving two key activities D 1 -ketosteroid dehydrogenase (KSTD) and 3-ketosteroid 9a-hydroxylase (KSH) (van der Geize et al., 2001; Knol et al., 2008; Wei et al., 2010b; Fern andez de las Heras et al., 2012; Rohman et al., 2013; Petrusma et al., 2014; Yao et al., 2014) . KSH is a two component class IA monooxygenase comprised of the terminal oxygenase KshA and the reductase component KshB (Andor et al., 2006; van der Geize et al., 2008; Petrusma et al., 2009; Capyk et al., 2009a,; Petrusma et al., 2011; Penfield et al., 2014) This enzyme introduces a 9a-hydroxyl group fundamental for steroid B-ring opening and thus, for its further degradation Petrusma et al., 2014) . The expression of the genes encoding the enzymes involved in the side-chain and the A-B rings degradation as well as those encoding the sterol uptake system, is controlled by the KstR repressor, a TetR-like transcriptional regulator (Kendall et al., 2007; Uh ıa et al., 2011) , while the expression of the genes responsible for the catabolism of C-D rings is regulated by a second TetR-like transcriptional regulator, the KstR2 repressor (Kendall et al., 2010; Casabon et al., 2013; Crowe et al., 2015; Garc ıa-Fern andez et al., 2015) . Accordingly to the above postulated pathway, C-19 steroids (e.g. AD, ADD and 9OH-AD) are considered central intermediates in the sterol catabolism. This hypothesis is in agreement with the finding that many microorganisms able to metabolize sterols can also use several C-19 steroids as sole carbon and energy sources (van der Geize et al., 2000; Fern andez de las Heras et al., 2009; Petrusma et al., 2011; Li et al., 2014) . Intriguingly, these bacteria have other sets of enzymes degrading steroids, different from those participating into the cholesterol catabolism, that are specifically induced by different C-19 steroids Petrusma et al., 2011; Fern andez de las Heras et al., 2012; Li et al., 2014) . In this scenario the different steroid catabolic pathways would be partially overlapped in some bacteria creating a complex network of metabolic intermediates that are degraded by a battery of redundant enzymes.
The conclusions presented in this work reveal the existence of a new silent and tightly regulated catabolic pathway in M. smegmatis, that is not induced by sterols (e.g. cholesterol, phystosterols) nor by C-19 steroids (e.g. AD, ADD, 9OH-AD), but which, after its desilencing/activation, confers to this strain the capacity to degrade these and other C-19 steroids. This finding has allowed us to reformulate the catabolism of cholesterol in M. smegmatis.
Results

Growth on C-19 steroids: the C-191 phenotype
It is well known that M. smegmatis mc 2 155 is able to grow on cholesterol as a sole carbon and energy source (Sobel and Plaut, 1949; Av-Gay and Sobouti, 2000; Kendall et al., 2007; Uh ıa et al., 2012) . To determine if this strain is able to grow on C-19 steroids, we cultured the bacterial cells in minimal medium containing cholesterol, AD, ADD or 9OH-AD as the sole carbon and energy sources. As it is shown in the Fig. 1A the bacterium only grew in the presence of cholesterol and no growth was detected in the presence of C-19 steroids. Assuming that the observed lag-phase could be exceptionally longer for these compounds and that M. smegmatis mc 2 155 might require more time to become fully adapted to the C-19 steroids we expanded the cultivation time. In this sense, we observed that after more than 120 h of incubation on AD, ADD or 9OH-AD containing minimal media, M. smegmatis mc 2 155 started to grow very efficiently, being able to reach a high cellular density at 150 h (Fig. 1B) . To check whether the new phenotype (named C-191 phenotype) was stable, the cells were collected after 150 h of cultivation on C-19 steroids and plated on solid media (LB or 7H9) to isolate individual colonies. After several passages in liquid or solid rich media (LB or 7H9) in the absence of any steroid, these C-191 strains retained the ability to degrade efficiently C-19 steroids without the previous lag phase (Fig. 1C) .
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Interestingly, the cells that were adapted to grow on a particular C-19 steroid (e.g. AD) were also able to grow on the other C-19 steroids (e.g. AD, ADD and 9OH-AD). As expected, the C-191 strains also retained their capacity to grow on cholesterol (data not shown). These experiments were repeated several times with identical results. In addition, any contamination with other strains was discarded by sequencing the amplified 16S-rRNA gene by PCR at the end of the cultures.
Unravelling the C-191 phenotype
It has been demonstrated that M. smegmatis mc 2 155 is able to transport efficiently different C-19 steroids (e.g. AD) (Fern andez-Cabez on et al., 2017) and hence, the inability to use C-19 steroids as carbon sources cannot be due to transport problems. Therefore, we ascribed this behaviour to the fact that the cholesterol pathway might be more tightly regulated in M. smegmatis mc 2 155 than in other C-19 steroid degrading bacteria, and thus, these compounds might be metabolized only after the complete activation of the kstR regulon that only responds to some CoAderivatives of the side chain as inducers (Garc ıa-Fern andez et al., 2014; Ho et al., 2016) . To check this hypothesis, we investigated whether the DkstR mutant of M. smegmatis (DMSMEG_6042), expressing constitutively the kstR regulon (Kendall et al., 2007; , was able to grow on C-19 steroids as the only carbon and energy sources. We found that the DkstR mutant was able to grow on AD or ADD but not on 9OH-AD (Fig. 2) , however, the growth rates on AD or ADD and the OD 600 were significantly lower than those observed in the C-191 strains (Fig. 1C) . The analysis by thin layer chromatography (TLC) of the culture supernatants from the DkstR mutant showed only a partial degradation of AD and ADD and the accumulation of several intermediates (data not shown). These results strongly suggested that AD and ADD cannot be efficiently degraded by the enzymes of the kstR regulon (e.g. KstD and/or KshAB). Moreover, the finding that 9OH-AD could not be metabolized by the DkstR mutant suggests that KstD cannot use 9OH-AD as substrate to form 9OH-ADD required to open B-ring.
To further discard the implication of the kstR regulon on the C191 phenotype, the transcription levels of some of Table 1) . Total RNA was isolated from mycobacterial cells growing in minimal medium containing cholesterol, glycerol or AD as the sole carbon and energy sources. To analyse gene expression in the presence of AD in M. smegmatis mc 2 155, glycerol was added to support the cell growth. In both strains the expression of the genes of kstR regulon was increased only in the presence of cholesterol but not in the presence of C-19 steroids and/ or glycerol (Supporting Information Fig. S1 ), showing that the transcriptional regulation of the kstR regulon was not altered in the C-191 strains.
These results taken together prompted us to postulate that M. smegmatis had a specific new set of enzymes responsible for the catabolism of C-19 steroids that was activated in the C-191 strains. These strains might have acquired the new ability to metabolize C-19 compounds by Molecular characterization of a new gene cluster 2549 some stable mutation(s). Taking into account that we have not submitted the cells to a mutagenic procedure, these mutants should be present within the initial cell population used as inoculum and/or be generated during the long lag phase due to the stress starvation conditions. Some experiments using the same inoculum to inoculate different independent cultures containing a variety of C-19 steroids indicate that the mutants were already present in the inoculum (data not shown). The 120 h delay to produce an observable amount of biomass could be explained since only few mutant cells should be present in the inoculum. Finally, to discard that the inability of M. smegmatis mc 2 155 to grow in C-19 steroids was due to the presence of superfluous mutations maybe acquired by this strain when it was mutated to become a high-frequency transformation mutant (Snapper et al., 1990; Etienne et al., 2005) , we cultured the reference wild type strain M. smegmatis DSM 43465 (ATCC 607) on C-19 steroids as carbon sources. This hypothesis was discarded since this strain was also unable to grow on these compounds as the only carbon and energy sources after four days, (data not shown). Furthermore, when the reference strain DSM 43465 was cultured on C-19 compounds as the sole carbon and energy source for more than 120 h of culture it showed the similar stable C-191 phenotype than the mc 2 155 strain (data not shown).
Using different C-19 steroids as carbon and energy sources in the selection procedure above described, we isolated in different independent experiments a large number of C-191 pure clones that have been further characterized in this work (Table 1) .
In silico identification and annotation of the C-191 gene cluster
The data presented above show that the C-191 strains metabolized AD, ADD and 9OH-AD most likely by using genes that are currently silent or that encode proteins that are currently inactive in M. smegmatis. Taken into account the key role of kshA1, kshB1 and kstD1 genes in cholesterol catabolism (Gal an et al., 2017), we searched for the presence of homologues in the M. smegmatis mc 2 155 genome. In this sense, Brzostek et al. (2005) had already described the presence of six putative kstD-like genes in M. smegmatis. We found one additional kshA gene, renamed as kshA2 (MSMEG_2870), that might encode a putative KshA enzyme of 386 aa with a deduced molecular weight of 43624 Da and a sequence similarity of 59% to KshA1 (MSMEG_5925) ( Table 2 ). The kshA2 gene had not been related to cholesterol catabolism before since its expression is not induced by cholesterol (Kendall et al, 2007; Uh ıa et al., 2012) . In the near vicinity of kshA2 gene we found two genes (MSMEG_2869 and MSMEG_2867) encoding two putative KstDs (KstD2 and KstD3) already described by Brzostek et al. (2005) (Table 2) . Surrounding these genes, we identified a 50 kb gene cluster encoding putative enzymes related to steroid metabolism, including a putative kshB2 gene (Supporting Information Table S1 ). Apparently, genes encoding the putative KstD4, KstD5 and KstD6 enzymes (Brzostek et al., 2005) are not surrounded by any gene related to steroid metabolism and were not further studied.
Based on the knowledge of cholesterol pathway in M. smegmatis , within the 50 kb cluster Table 2 . In silico identification of homologous genes involved in the degradation of steroid A/B rings in M. smegmatis mc 2 155. Genes from the cholesterol catabolism were previously described by Garc ıa et al. (2012) . Identities were established using the proteins of cholesterol pathway as references and are shown in parentheses.
Protein
Biochemical function Cholesterol Pathway C191 Pathway (% identity)
MSMEG_2893 (55) (kshB2) HsaA 3-Hydroxy-9,10-secoandrosta-1,3,5(10)-trien-9, 17-dione monooxygenase, oxygenase subunit
MSMEG_2892 (40) (hsaA2) HsaB 3-Hydroxy-9,10-secoandrosta-1,3,5(10)-trien-9, 17-dione monooxygenase, reductase subunit
HsaC 3,4-Dihydroxy-9,10-secoandrosten-1,3,5(10)-trien-9, 17-dione dyoxigenase
MSMEG_2891 (50) (hsaC2) HsaD 4,5,9,10-Diseco-3-hydroxy-5,9,7-trioxoandrosta-1(10), 2-diene-4-oic acid hydroxylase
we identified homologous genes for almost all the postulated enzymatic steps involved into the A/B steroid ring modification (KstD, KshA, KshB, HsaA, HsaC, HsaD) (Table 2) . Interestingly, a putative steroid monooxygenase (SMO) encoded by MSMEG_2894 gene shares 67% protein identity to a protein (WP_059384609) from Rhodococcus rhodochrous that has been described as a versatile biocatalyst converting a large range of different ketone steroid substrates into lactones utilizing molecular oxygen and NADPH (Morii et al., 1999; Leipold et al., 2013) . Moreover, within this region, we annotated three putative transcriptional regulators. The MSMEG_2868 gene encodes a putative regulator of the PadR family (accession no. Pfam PF03551) (Fibriansah et al., 2012) (Cuthbertson and Nodwell, 2013) . Summarizing, the in silico analysis revealed that M. smegmatis contains a gene cluster (from MSMEG_2851 to MSMEG_2901 genes) that might encode the enzymes involved in the degradation of C-19 compounds. Therefore, this cluster was initially named C-191 gene cluster and its 
Gene expression analysis of the C-191 gene cluster
To check whether the ability to degrade C-19 steroids in the C-191 strains was due to the expression of the genes located in the potential C-191 gene cluster, the transcription levels of some of the key genes within this region were analysed by semi-quantitative RT-PCR in the wild type and in several C-191 strains (Table 1) . These genes were constitutively expressed in the C-191 cells independently of the carbon source used in the culture media (i.e. glycerol, cholesterol or AD) (Fig. 3) . The observation that the expression of the C-191 gene cluster is not induced by C-19 steroids in the wild type strain explains why it is unable to grow on these compounds (Fig. 3A) .
Additionally we checked that the expression of the C-191 gene cluster was not up-regulated in the M. smegmatis DkstR (DMSMEG_6042) mutant or in the wild type strain in the presence of cholesterol (Fig. 3A) , confirming that the genes of the C-191 cluster are not members of the kstR regulon (Kendall et al., 2007; Uh ıa et al., 2012) .
Finally, we observed that the expression of the MSMEG_6000 and MSMEG_6012 genes, two members of the kstR2 regulon, was increased in the C-191 cells growing on C-19 steroids (Supporting Information Fig. S2 ). This result indicates that the catabolism of the C-19 steroids in the C-191 cells produces an intermediate that is able to activate the kstR2-regulon (Casabon et al., 2013; Garc ıa-Fern andez et al., 2015) . This suggests that in the C-191 cells the C/D rings of C-19 steroids are most probably catabolized by the enzymes encoded by the kstR2-regulon of cholesterol. Thus, we propose that the new C-191 pathway and the cholesterol pathway converge at least in the compounds that constitute the so call lower cholesterol pathway.
Moreover, we propose that the C-191 and the cholesterol pathways converge in an intermediate even before reaching the lower cholesterol pathway. In this sense, a basal expression of the MSMEG_5940 gene (hsaE), that is part of the putative operon hsaEFG (MSMEG_5940_ 5939_5937) involved into the 2-hydroxy-2,4-hexadienoic acid degradation, was observed in the M. smegmatis strains in presence of glycerol or C-19 steroids (Supporting Information Fig. S1 ). C-19 steroid catabolism in the C-191 cells might also converge with the cholesterol pathway though the intermediate 2-hydroxy-2,4-hexadienoic acid, using since this point the genes/enzymes of the cholesterol pathway to fully catabolize the C-19 compounds.
Identification of the mutations responsible for the C-191 phenotype
The results presented above demonstrated that the genes from the C-191 gene cluster were constitutively overexpressed in the C-191 cells, suggesting some modifications in a regulatory protein or a regulatory circuit. As mentioned above, within the C-191 gene cluster, we had identified three putative transcriptional regulatory genes (MSMEG_2868, MSMEG_2890 and MSMEG_ 2898) encoding PadR-like, IclR-like and TetR-like proteins respectively.
These regulatory genes from the wild type strain and one of the C-191 strains (ADD1) were amplified by PCR and sequenced (Table 1 ). The padR gene from the ADD1 contained a 9 bp deletion (Table 3) whereas the iclR and the tetR genes remained unmodified, suggesting that the mutation in padR could be responsible for the C-191 phenotype.
To further confirm the implication of the padR gene, we extended these analyses to other isolated C-191 strains (Table 1) . The M1 strain presented a 9 bp deletion within the padR gene located in the region encoding the DNAbinding domain of the regulator (Table 3) .
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The amplification of the padR gene was not possible in the M2, a C-191 strain derived from the reference strain M. smegmatis DSM 43465, using the primers MSMEG_2868seqF and MSMEG_2868seqR. However, using more external primers MSMEG_2858qF and MSMEG_2870seqR that hybridize in MSMEG_2858 and MSMEG_2870 genes, respectively, there was an amplification of a 3.8 Kb DNA fragment. After sequencing this amplicon, we found a large deletion of 8.3 kb which extends from MSMEG_2858 to MSMEG_2868 and includes the padR gene (Table 3 ). Taking into account that the M2 strain presents the same capacity to degrade C-19 steroids than the rest of mutants, it can be inferred that the other genes deleted together with padR are not essential to degrade the C-19 compounds. This result points out that only KstD2 encoded by MSMEG_2869 and not KstD3 encoded by MSMEG_2867 is playing a key role in the degradation of C-19 compounds.
The M3 strain was derived from the double mutant M. smegmatis M6039-5941 (DkshB1, DkstD1), a strain metabolically engineered to accumulate AD from cholesterol . After sequencing of the padR gene in M3, we identified a single point mutation promoting an amino acid change (A114W).
In the M4 and M5 strains we detected insertions of 15 bp and 45 bp within the padR gene respectively. Curiously, both insertions produced duplications of 3 amino acids (aa 131-133) in M4 and of 15 amino acids (165-179) in M5.
All these results suggest that the C-191 phenotypes are produced by the modification/inactivation of the PadR regulator that trigger directly or indirectly the constitutive expression of several genes of the C-191 gene cluster. Although these results do not preclude that the iclR and/or tetR genes might also play a role in the C-191 phenotype, all the subsequent works were only focussed in the padR gene, since the study of the roles of iclR and tetR genes should require further and different genetic and biochemical approaches once established the existence of a new pathway.
Construction of a DpadR mutant
To determine that the inactivation of PadR regulator (MSMEG_2868 gene) was enough to cause the C-191 phenotype, we constructed by double homologous recombination a DpadR mutant in M. smegmatis mc 2 155, named MS2868. The correct deletion of padR gene was confirmed by PCR (Supporting Information Fig. S3 ). Accordingly to our hypothesis, the M. smegmatis MS2868 (DpadR) mutant was able to grow on minimal medium containing AD, ADD or 9OH-AD as sole carbon and energy sources (Fig.4) . Moreover, the MS2868 mutant grows using glycerol or cholesterol as sole carbon and energy sources (data not shown). To ascertain that the deletion of the padR gene was the only mutation responsible of the C-191 phenotype in MS2868 mutant and no other mutations have been added to this mutant, we complemented MS2868 in trans with a wild type padR gene. Thus, the padR gene was cloned into the pMV261 plasmid yielding plasmid pMVPadR that was used to transform MS2868. The recombinant strain M. smegmatis MS2868 (pMVPadR) lost the ability to grow on C-19 steroids as carbon and energy sources, but it grew on other carbon sources such as glycerol (data not shown). To demonstrate the implication of the PadR regulator in the growth on C-19 compounds, the expression of several genes from the C-191 gene cluster was analysed by RT-PCR in the strains M. smegmatis MS2868 and the complemented M. smegmatis MS2868 (pMVPadR) (Supporting Information Fig.  S4 ). These results demonstrate that PadR represses the expression of the genes from the C-191 gene cluster rendering the complemented recombinant cells unable to metabolize C-19 compounds.
Identification of the C-191 cluster in other bacterial species
The presence of the C-191 cluster in other bacterial species was confirmed by an in silico analysis. First, we searched homologues of padR (MSMEG_2868) and iclR (MSMEG_2890) genes in the databases and analysed their genomic context looking for other homologous genes of the M. smegmatis C-191 gene cluster.
Following this approach, we observed that C-191 clusters are widely distributed in many mycobacterial species. Several mycobacteria isolated from environmental sources, such as M. vanbaalenii PYR-1 (from MVAN_RS14310 to MVAN_RS14565) and M. neoaurum DSM 44074 (ATCC 25795) (from TY28_RS11880 to TY28_RS12130) contain (Fig. 5) .
We have also detected the presence of putative C-191 clusters in numerous actinobacterial species such as the model bacteria R. jostii RHA1, Gordonia neofelifaecis NRRL-B59395 and Nocardioides simplex VKM Ac-2033D (Supporting Information Fig. S5A ).
On the other hand, we analysed the presence of the C-191 gene cluster in several mycobacteria that are currently used at industrial scale for the production of C-19 steroids (e.g. AD, ADD or 9OH-AD) from natural sterols as feedstock. Most of these strains have been isolated from environmental samples and improved after wide mutagenesis and screening programs. This is the case of the ADproducing strains M. neoaurum VKM Ac-1815D and Mycobacterium sp. NRRL B-3805, whose genomes have been recently sequenced (Shtratnikova et al., 2014 ; Rodr ıguez- Garc ıa et al., 2016). Interestingly, none of these strains have the C-191 gene cluster. When we compared the genomes of the industrial strains of M. neoaurum VKM Ac-1815D and Mycobacterium sp. NRRL B-3805 with the genome of the reference M. neoaurum DSM 44074 strain, a close phylogenetic strain that contains the C-191 gene cluster, we observed a precise deletion of this cluster in both AD-producing industrial strains (Supporting Information Fig. S5B) .
Finally, to demonstrate a direct correlation between the presence of the C-191 gene cluster and the ability of growing on C-19 steroids in other actinobacteria, we tested the ability of M. neoaurum DSM 44074 and Mycobacterium sp. NRRL B-3805 to grow on minimal medium containing AD as the sole carbon and energy source. Taking into account that Mycobacterium sp. NRRL B-3805 has not the C-191 cluster, we confirmed that as expected it was unable to grow on AD as the sole carbon and energy source even after more than 500 h of incubation (data not shown). However, the M. neoaurum DSM 44074 strain presented the same behaviour than M. smegmatis, this is, it was able to grow on AD only after 120 h of incubation. The cells of M. neoaurum DSM 44074 isolated at the end of this culture period had acquired the stable C-191 phenotype already described for M. smegmatis (data not shown). When the padR gene from the wild type M. neoaurum DSM 44074 (locus tag: TY28_RS12035; protein id: WP_036470770.1) and two isolated C-191 mutant strains (DSM44074 1 1 and DSM44074 1 2) was amplified and sequenced (Table 1) , we found two different 1 bp insertions (221_222insG and 210_211insT, respectively) that generate truncated PadR proteins in the mutant strains. These results confirmed the role of the C-191 cluster in the acquisition of the C-191 phenotype as well as the involvement of padR on the cluster regulation in other mycobacteria.
Discussion
Conventionally, it has been assumed that AD, ADD and 9OH-AD are intermediates of the cholesterol catabolic pathway in M. smegmatis . First, these compounds have been found in the culture medium of other bacteria degrading sterols. Second, there are several examples of bacteria able to use both cholesterol and C-19 steroids as efficient carbon and energy sources such as Rhodococcus erythropolis strain SQ1 (van der Geize et al., 2000) , Rhodococcus ruber strain Chol-4 (Fern andez de las Heras et al., 2009), R. rhodochrous DSM 43269 and Gordonia neofelifaecis NRRL B-59395 (Li et al., 2014) . Third, there are some developed metabolic engineered mutant strains that accumulate C-19 steroids (e.g. AD, ADD or 9OH-AD) from cholesterol, suggesting that these compounds could be certainly intermediates of the cholesterol catabolic pathway (e.g. Gal an et al., 2017) .
In contrast to this hypothesis, it has been proposed that some of the enzymes involved into the cholesterol catabolism use as preferred substrates acyl-CoA derivatives resulting from the b-oxidation of the side-chain. i.e. compounds that still retain 3 or more carbons of the sterol sidechain (Capyk et al., 2011; Penfield et al., 2014) . In fact, by inhibiting the B-ring opening of cholesterol, it is possible to observe the accumulation in the culture media of C-22 and C-24 intermediates (Szentirmai, 1990; Wilbrink et al., 2011; Yeh et al., 2014; Gal an et al., 2017) . Donova et al. (2005) have also proposed that the 9a-hydroxylation occurs at the earlier steps of sterol side-chain degradation and thus, the formation of 9OH-AD is mostly a result of side-chain degradation of 9a-hydroxylated steroids with a side-chain at C-17. The data presented demonstrate that the bacterium M. smegmatis mc 2 155 as well as its parental reference strain M. smegmatis DSM43465 cannot naturally use C-19 steroids as the sole carbon and energy sources (Fig. 1) . This behaviour cannot be attributed to regulatory constraints (Garc ıa-Fern andez et al., 2014; Ho et al., 2016) since the M. smegmatis DkstR (DMSMEG_6042) mutant can metabolize AD or ADD very inefficiently, but cannot metabolize 9OH-AD at all (Fig. 2) . Therefore, we propose that AD, ADD, and 9OH-AD might not be true intermediates of the cholesterol catabolism in M. smegmatis.
On the other hand, our results demonstrate that M. smegmatis mc 2 155 is in fact equipped with a set of genes required to metabolize efficiently C-19 steroids (Fig. 1B) .
The mutants isolated at the end of the adapted cultures, named C-191 strains, acquired a stable C-191 phenotype, conferring them the ability to grow very efficiently in C-19 steroids with a short lag-phase (Fig. 1C) . By in silico analysis, we identified a large genomic region named C-191 gene cluster (from MSMEG_2851 to MSMEG_2901) (Fig. 5) that contains many genes which have been annotated as putative steroid degrading enzymes and several putative transcriptional regulators (Supporting Information  Table S1 ). Transcriptomic analyses confirmed that the genes of this C-191 gene cluster remain silent in the wild type strain, both in the presence of cholesterol or in the presence of C-19 compounds, but they were constitutively expressed in the C-191 strains (Fig. 3) . We found out that the C-191 strains isolated showed different mutations in a padR-like regulatory gene found within the C-191 gene cluster (Table 3) . PadR-like transcription factors belong to a large and diverse family of regulators that were found both in Bacteria and Archaea, but only few of them have been functionally characterized (Fibriansah et al., 2012; Isom et al., 2016) . These regulators share a characteristic N-terminal winged HTH DNA binding domain (PF03551) and bear a variable C-terminal domain responsible for Molecular characterization of a new gene cluster 2555 dimerization and effector recognition. M. smegmatis uses different strategies to inactivate this padR-like gene because we found insertions, deletions and single point mutations affecting indistinctly the N-and C-terminal domains of PadR protein. The DpadR mutant of M. smegmatis constructed by site-directed mutagenesis confirmed that PadR is as a transcriptional regulator that represses directly or indirectly the expression of the genes contained in the C-191 gene cluster (Fig. 4; Supporting Information  Fig. S4) .
The in silico analyses carried out to identify the presence of the C-191 gene cluster in other mycobacterial species confirmed that several environmental mycobacteria such as M. vanbaalenii PYR-1 or M. neoaurum DSM 44074 contain this C-191 gene cluster and strictly pathogenic mycobacteria such as M. tuberculosis H37Rv do not. We also found out that well known industrial AD-producing strains, like M. neoaurum VKM Ac-1815D and Mycobacterium sp. NRRL B-3805, do not have the C-191 gene cluster. Interestingly, we determined precisely the genomic position for the evolved deletion/insertion of this cluster when the genomes of these industrial bacteria were compared to the genome of the close phylogenetic strain M. neoaurum DSM 44074 that contains the C-191 gene cluster (Supporting Information Fig. S5) . Furthermore, M. neoaurum DSM 44074 behaves as M. smegmatis, i.e. it cannot use initially C-19 compounds as carbon and energy sources but can acquire the C191 phenotype by inactivating the padR gene. The fact that in M. smegmatis the C-191 gene cluster is not induced by C-19 steroids (e.g. AD, ADD, 9OH-AD) or sterols (e.g. cholesterol, phytosterols) suggests that this cluster has evolved for degrading other structurally related compounds not yet identified. We propose that the C191 catabolic cluster was acquired and/or conserved in M. smegmatis and other mycobacterial strains because it might play a nutritional role that is dispensable for the survival of M. tuberculosis. At this point the substrate/inducer(s) of this cluster cannot be anticipated, but we can assume that M. smegmatis could find in the environment a diversity of steroids or steroid-like compounds that M. tubercolusis could not find in its current niche. Nevertheless, we cannot completely discard that the regulatory gene(s) that control the expression of the C-191 gene cluster might have lost the capacity for recognizing C-19 compounds as inducers in M. smegmatis and in other strains. In fact, we also identified by in silico analyses other putative C-191 gene clusters in several actinobacterial species degrading C-19 steroids (Supporting Information Fig. S5 ). For example, the genes of a similar cluster were proposed to be induced by AD and/or cholesterol in G. neofelifaecis (Li et al., 2014) . Other works have also demonstrated that the mineralization of C-19 compounds requires alternative enzymes in bacteria such as R. rhodochrous DSM 43269 or R.
ruber strain Chol-4 (Fern andez de las Heras et al., 2012) . Thus, only those bacteria having this additional gene cluster appear to be efficient degraders of C-19 compounds. Li et al. (2016) has recently published a genome-wide transcriptome profiling of M. smegmatis mc 2 155 cultivated in minimal media supplemented with cholesterol, AD or glycerol, also suggesting that this strain is able to grow in AD. These analyses indicated that cholesterol induced a large number of genes in agreement with other microarray analyses (Kendall et al., 2007; Uh ıa et al., 2012) . However, in this work AD did not produce the same response than cholesterol and did not induce another different set of catabolic genes. Analysing the supplementary date supplied by these authors, we have observed that AD did not induce the C-191 gene cluster. Li et al. (2016) explain that the minimal media used for RNA-seq contained all macroelements sufficient to maintain basic metabolism and growth, including an important amount of ammonium acetate (1.5 g/L) as a carbon source that could explain the apparent growth observed in the presence of AD. Therefore, in agreement with our results, AD did not induce the kstR regulon neither the C-191 gene cluster in M. smegmatis mc 2 155 in the work of Li et al. (2016) and most probably the growth observed in AD is due to acetate. On the other hand, several authors have described the metabolism of AD in certain mycobacterial species (e.g. M. smegmatis mc 2 155, M. neoaurum ATCC 25795) (Brzostek et al., 2005; Yao et al., 2013) . However, those experiments were performed by monitoring the disappearance of AD in culture media with additional carbon and energy sources (e.g. glycerol and glucose), so their conclusions cannot be compared with our work. Hu et al. (2010) published that M. tuberculosis is able to use AD as a carbon source although M. tuberculosis strains do not contain the C-191 gene cluster. It is known that AD does not induce the kstR regulon (Garc ıa-Fern andez et al., 2014; Ho et al., 2016) , so M. tuberculosis should not grow in AD in the absence of cholesterol unless this strain has a higher basal expression level of the kstR regulon and/or contains KshAB and KstD enzymes that are more active on C-19 compounds than the corresponding enzymes of M. smegmatis.
Summarizing, the results presented above demonstrate that AD, ADD and 9OH-AD should not be considered as true intermediates of the cholesterol pathway in M. smegmatis, as well as in some related mycobacteria. The metabolism of these compounds can be efficiently carried out by a new pathway called the C-191 pathway that does not belong to the kstR regulon (Fig. 6 ). This new pathway is encoded by the C-191 gene cluster that is transcriptionally regulated by a PadR-like regulator encoded by the MSMEG_2868 gene. Our results suggest that the new C-191 and cholesterol pathways converge on a common route for degradation of steroid C and D rings that is regulated by KstR2. A similar convergence of the cholesterol and cholate pathway was described in Rhodococcus jostii RHA1 (Mohn et al., 2012) . Remarkably, the C-191 pathway appear to have evolved independently from the cholesterol pathway since it is not always present in microorganisms that degrade cholesterol such as M.
Molecular characterization of a new gene cluster 2557 tuberculosis. Based on our findings and other results (Donova et al., 2005; Capyk et al., 2011) we also propose that AD, ADD and 9OH-AD must be now considered as side products of the cholesterol pathway in M. smegmatis and thus, the steroid catabolic pathways might be reformulated according to the scheme of Fig. 6 . We are currently developing laborious studies to determine the specific roles of all the regulatory and enzyme coding genes of the C-191 gene cluster of M. smegmatis and to find the inducer of this cluster.
Experimental procedures
Chemicals 4-Androstene-3,17-dione (AD) and 1,4-androstadien-3,17-dione (ADD) were purchased from TCI America. Glycerol was purchased from Merck (Darmstardt, Germany). Cholesterol, Tween 80, tyloxapol, gentamicin and kanamycin were from Sigma (Steinheim, Germany). 9a-Hydroxy-4-androstene-3,17-dione (9OH-AD) was kindly provided by Gadea Biopharma (Le on, Spain).
Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids used in this work are listed in Table 1 . M. smegmatis and other Mycobacterium sp. strains were grown in an orbital shaker at 200 r.p.m. at 378C and 30 C respectively. Middlebrook 7H9 broth medium (Difco) supplemented with 0.4% glycerol and 0.05% Tween 80 or Luria-Bertani medium supplemented with 0.05% Tween 80 were used as rich medium. 7H9 broth without any supplement was used as minimal medium. 7H10 agar (Difco) plates supplemented with 10% albumin-dextrose-catalase (Becton Dickinson) or LB agar plates were used for solid media. Gentamycin (5 mg ml
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) or kanamycin (20 mg ml 21 ), were used for strain selection when appropriate. All the steroids were dissolved in 10% tyloxapol prior to its addition to the minimal medium. Due to the low solubility of these compounds, the stock solutions were warmed at 808C in agitation, sonicated in a bath for 1 h and then autoclaved.
Escherichia coli DH10B strain was used as a host for cloning. It was grown in LB medium at 378C in an orbital shaker at 200 rpm LB agar plates were used for solid media. Gentamycin (10 mg ml 21 ) or kanamycin (50 mg ml 21 ), were used for plasmid selection and maintenance.
DNA manipulations and sequencing
DNA manipulations and other molecular biology techniques were essentially as described by Sambrook and Russell (2001) . Oligonucleotides used at this work are listed at Supporting information (Supporting Information Table S2 ) and were purchased from Sigma-Aldrich. DNA amplification was performed on a Mastercycler Gradient (Eppendorf) using DNA polymerase I and Pfu polymerase from Biotools B.M. Labs. Reaction mixtures contained 2 mM MgCl 2 and 0.25 mM dNTPs. DNA fragments were purified with High Pure PCR System Product Purification Kit (Roche). Restriction enzymes were obtained from various suppliers and were used according to their specifications. Plasmid DNA was prepared with a High Pure Plasmid Isolation Kit (Roche Applied Science). Genomic DNA purification from mycobacterial species was performed as previously described (Uh ıa et al., 2011). E. coli was transformed by the rubidium chloride method (Wirth et al., 1989) . M. smegmatis cells were transformed by electroporation (Gene Pulser; Bio-Rad) (Parish and Stoker, 1998) . All cloned inserts and DNA fragments were confirmed by DNA sequencing through an ABI Prism 377 automated DNA sequencer (Applied Biosystems Inc.) at Secugen S.L. (Madrid, Spain).
Gene deletion
The knock-out strain MS2868 was constructed by double homologous recombination using the plasmid pJQ200x, a derivative of the suicide vector pJQ200 that does not replicate in Mycobacterium (Jackson et al., 2001) . The strategy consisted in amplifying by PCR two fragments of 700 bp containing the upstream region (UP fragment) and the downstream region (DOWN fragment) of the MSMEG_2868 gene to be deleted (Supporting Information Table S2 ). The two amplicons were purified, digested with the corresponding enzymes and cloned into the plasmid pJQ200x using E. coli DH10B competent cells. The resulting plasmid pJQPadR was electroporated into competent M. smegmatis mc 2 155. First, the single cross-overs were selected on 7H10 agar plates containing gentamycin. The obtained single colonies were also contra-selected in 10% sucrose and the presence of the xylE gene was confirmed by the appareance of yellow coloration after spreading catechol over them. Second, to select for double cross-overs, a single colony was grown in rich medium up to an optical density of 0.8-0.9 and several culture dilutions were plated onto 7H10 agar plates with 10% sucrose. Potential double cross-overs (sucrose-resistant colonies) were in -dehydrogenase (KstD); 3-ketosteroid-9a-hydroxylase (KshAB); 3-HSA monooxygenase (HsaAB); 3,4-HSA dyoxigenase (HsaC); (4,9-DSHA) hydroxylase (HsaD); 2-hydroxy-2,4-hexadienoic acid hydratase (HsaE); 4-hydroxy-2-hydroxy-2-ketovalerate aldolase (HsaF); acetaldehyde dehydrogenase (HsaG). Abbreviations of metabolites: 4-androstene-3,17-dione (AD); 1,4-androstadiene-3,17-dione (ADD); 9a-hydroxy-4-androstene-3,17-dione (9OH-AD); 9a-hydroxy-1,4-androstadiene-3,17-dione (9OH-ADD); 3-hydroxy-9,10-secoandrosta-1,3,5(10)-trien-9,17-dione (3-HSA); 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-trien-9,17-dione (3,4-HSA); 4,5,9,10-diseco-3-hydroxy-5,9,7-trioxoandrosta-1(10),2-diene-4-oic acid (4,9-DSHA); 3aa-H-4a(3-propionic acid)27ab-methylhexahydro-1,5-indanedione (HIP).
addition screened for gentamycin sensitivity and the gene deletion was confirmed by PCR.
Complementation of the MS2868 mutant with padR
To isolate the MSMEG_2868 gene encoding PadR from M. smegmatis mc 2 155, its genomic DNA was extracted and amplified by PCR using the primers PadR_F and PadR_R (Supporting Information Table S2 ). The resulting amplicon was purified and digested with BamHI and EcoRI to be cloned into the expression vector pMV261 (Stover et al., 1991) , a shuttle plasmid that replicates in E. coli and Mycobacterium, generating the plasmid pMVPadR. It was transformed into E. coli DH10B for cloning purposes and once its sequence was verified, it was used to transform electrocompetent cells of M. smegmatis MS2868. The mutant strain carrying the plasmid pMV261was used as a control.
Semi-quantitative RT-PCR assays
Total RNA was extracted from mycobacterial cells grown in minimal medium with 3.6% tyloxapol and different carbon sources (18 mM glycerol, 1.8 mM cholesterol or 1.8 mM AD). Cells were harvested in the exponential phase (OD 600 0.8-0.9), recollected by centrifugation at 48C and stored at 2808C. Pellets were thawed and cells were lysed in 1 ml Kirby solution (1% SDS, 0.2 M EDTA) containing lysozyme (15 mg ml
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) by a series of freeze-thaw cycles. RNA was extracted using the Rneasy mini kit (Qiagen) according to the manufacturer's instructions. To reduce any contamination with DNA, samples were also treated with the Dnase Treatment and Removal Kit (Ambion). The concentration and purity of the RNA samples were measured by using an ND1000 spectrophotometer (Nanodrop Technologies). Synthesis of total cDNA was carried out with the Transcriptor First Strand cDNA Synthesis Kit (Roche) according to the manufacturer's instructions. RNA and Random Hexamer Primers were first heated to 658C for 5 min for primer annealing and after snap cooled on ice, the remaining components were added and then incubated first at 258C for 10 min and later at 558C for 30 min. The reactions were stopped by incubation at 858C for 5 min. Control reactions in which reverse transcriptase was omitted from the reaction mixture were done, ensuring the absence of DNA contamination in the initial samples. Then, the PCR amplification was performed in 50 ml of reaction mixture containing 0.5 ml of cDNA, 0.25 mM dNTPs, 0.5 mM of each primer, and 0.5 U of DNA polymerase I (Biotools B.M. Labs). The amplification of the sigA gene (MSMEG_2758), which is a constitutive gene expressed in all the conditions and strains analyzed, was used as positive control (Gomez and Smith, 2000) . The semiquantitaive RT-PCR products were analysed by electrophoresis on 1.5% agarose gels.
Bioinformatic analysis
Sequence alignments were carried out using Clustal W (Thompson et al., 1994) and different BLAST algorithms from the National Centre of Biotechnology Information Server (NCBI) were also used.
Supporting information
Additional Supporting Information may be found in the online version of this article at the publisher's website: Table S1 . Gene identification of the C-191 cluster in M. smegmatis mc 2 155. Table S2 . Oligonucleotides used in this study. Fig. S1 . Gene expression analysis of the kstR regulon by semi-quantitative RT-PCR in the M. smegmatis mc 2 155 and ADD1 strains. Total RNA was extracted from mycobacterial cells grown in minimal medium with 18 mM glycerol, 1.8 mM AD or 1.8 mM cholesterol. To analyse the gene expression in the presence of AD in M. smegmatis mc 2 155, 18 mM glycerol was added to support the cell growth. Control reactions without reverse transcriptase were done to verify absence of gDNA contamination (-). Abbreviations: HK (housekeeping). (Table S2 ). B) 1.5% agarose gel of the PCR performed for mutation verification by using the primers MSMEG_2868seqF and MSMEG_2868seqR. DNA agarose gel of the PCR performed for mutation verification using oligonucleotides 2868 seq F and 2868 seq R (Table S2 ). Line 1: UX174-HaeIII marker (NEB); line 2: wild type strain; line 3: DpadR strain. The expected size of the amplicons was 1.1 kb for WT and 0.5 kb for DpadR. Fig. S4 . Gene expression analysis of the C-191 cluster by semi-quantitative RT-PCR in several strains of M. smegmatis: mc 2 155, ADD1, MS2868, and MS2868 (pMVPadR). Total RNA was extracted from mycobacterial cells grown in minimal medium with 18 mM glycerol. Control reactions without reverse transcriptase were done to verify absence of gDNA contamination (-). Abbreviations: HK (housekeeping); MS2868c (MS2868 (pMVPadR)). 
